Khuong Chau Quang
Affiliate at Fusion Pharmaceuticals Inc.; Director at INSP; Director at Otonomy, Inc.
- Sold, on record
- $185M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Aug 18, 2020
- Form 144 notices
- 2
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- Fusion Pharmaceuticals Inc.Affiliate
- INSPInspire Medical Systems, Inc.Director
- Otonomy, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INSP2.4M shares
- Otonomy, Inc.406,304 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale INSPPlan not statedNov 27, 2019 2019
Sold 124,000 shares at $70.69 ($8.8M)
Khuong Chau Quang, Director
Sold 8.4% of holdings ($104M position)1.3M shares leftFiling
- 2 Form 4 sale INSPUnusualMar 4, 2020 +98 days
Sold 500,000 shares at $84.25 ($42.1M)
Khuong Chau Quang, Director
Sold 37.1% of holdings ($113M position)847,000 shares left1.4x usual sizeFiling
- 3 Form 4 sale INSPUnusualMar 6, 2020 +2 days
Sold 500,000 shares at $83.52 ($41.8M)
Khuong Chau Quang, Director
Sold 59% of holdings ($70.7M position)347,000 shares left1.2x usual sizeFiling
- 4 Form 4 sale INSPUnusualAug 11, 2020 +158 days
Sold 116,570 shares at $105.65 ($12.3M)
Khuong Chau Quang, Director
Sold 33.6% of holdings ($36.7M position)230,430 shares left0.2x usual sizeFiling
- 5 Form 4 sale INSPUnusualAug 14, 2020 +3 days
Sold 92,167 shares at $108.58 ($10M)
Khuong Chau Quang, Director
Sold 40% of holdings ($25M position)138,443 shares left0.2x usual sizeFiling
- 6 Form 4 sale INSPUnusualAug 18, 2020 +4 days
Sold 138,443 shares at $107.82 ($14.9M)
Khuong Chau Quang, Director
Sold 100% of holdings ($14.9M position)0 shares left0.4x usual sizeFiling
- 7 Form 144 notice Fusion Pharmaceuticals Inc.NoticeDec 8, 2023 +1207 days
Filed to sell 22,093 shares ($127k)
Khuong Chau Quang, Affiliate
No 10b5-1 planFirst sale on recordFiling
- 8 Form 144 notice Fusion Pharmaceuticals Inc.NoticeDec 14, 2023 +6 days
Filed to sell 22,093 shares ($122k)
Khuong Chau Quang, Affiliate
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | Dec 14, 2023 | Fusion Pharmaceuticals Inc. | Affiliate | Form 144 notice | 22,093 | $122k | Notice | SEC | |
| Dec 8, 2023 | Dec 8, 2023 | Fusion Pharmaceuticals Inc. | Affiliate | Form 144 notice | 22,093 | $127k | Notice | SEC | |
| Aug 18, 2020 | Aug 19, 2020 | INSP | Director | Form 4 sale | 138,443 | $14.9M | 100.0% | Unusual | SEC |
| Aug 14, 2020 | Aug 14, 2020 | INSP | Director | Form 4 sale | 92,167 | $10M | 40.0% | Unusual | SEC |
| Aug 11, 2020 | Aug 11, 2020 | INSP | Director | Form 4 sale | 116,570 | $12.3M | 33.6% | Unusual | SEC |
| Mar 6, 2020 | Mar 10, 2020 | INSP | Director | Form 4 sale | 500,000 | $41.8M | 59.0% | Unusual | SEC |
| Mar 4, 2020 | Mar 5, 2020 | INSP | Director | Form 4 sale | 500,000 | $42.1M | 37.1% | Unusual | SEC |
| Nov 27, 2019 | Nov 29, 2019 | INSP | Director | Form 4 sale | 124,000 | $8.8M | 8.4% | Plan not stated | SEC |
| Mar 8, 2019 | Mar 11, 2019 | INSP | Director | Form 4 sale | 358,449 | $20.5M | 19.6% | Plan not stated | SEC |
| Dec 11, 2018 | Dec 13, 2018 | INSP | Director | Form 4 sale | 614,772 | $23.1M | 25.2% | Unusual | SEC |
| Nov 30, 2015 | Nov 30, 2015 | Otonomy, Inc. | Director | Form 4 sale | 67,106 | $1.9M | 3.5% | Plan not stated | SEC |
| Nov 24, 2015 | Nov 24, 2015 | Otonomy, Inc. | Director | Form 4 sale | 200,800 | $5.7M | 9.5% | Plan not stated | SEC |
| Nov 19, 2015 | Nov 19, 2015 | Otonomy, Inc. | Director | Form 4 sale | 138,398 | $4M | 6.1% | Plan not stated | SEC |